CoChat

Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that is increasing worldwide due to increased life expectancy. AD is characterized by two pathological hallmarks in the brain: amyloid-β (Aβ) plaque deposits and neurofibrillary tangles. A focus of AD research has concentrated on either inhibiting Aβ peptide aggregation that leads to plaque formation or breaking down pre-formed Aβ peptide aggregates. An alternative approach is to modulate the Aβ aggregation profile by facilitating the formation of Aβ species that are off-pathway and non-toxic. Herein, we report the re-purposing of the widely studied Ru(iii) anti-cancer complex KP1019, towards regulating the aggregation profile of the Aβ peptide. Using electron paramagnetic resonance (EPR) spectroscopy, we conclude that KP1019 binds to histidine residues, located at the N-terminus of the peptide, in a rapid and robust fashion. Native gels and transmission electron microscopy (TEM) analyses have provided insight into the species and structures that are generated by KP1019-Aβ interactions. Finally, incubation in an in vitro human neuronal cell model has demonstrated that the formation of KP1019-Aβ species rescues cell viability from Aβ-associated neurotoxicity. Modulation of the Aβ aggregation pathway via covalent interactions with small molecules is thus a promising AD therapeutic strategy.

Overview

Integrity signals

Registry

Crossref · 10.1039/c4mt00252k

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 79 references

Research works printed but not linked: 3

  1. Galeano, 1992, Arzneim.-Forsch./Drug Res., 42, 821
  2. Kreuser, 1992, Semin. Oncol., 19, 73
  3. Kim, 1988, Neurosci. Res. Commun., 2, 121

Cited by

Metadata

Authors
Jones, M. R., Mu, C., Wang, M. C. P., Webb, M. I., Walsby, C. J., & Storr, T.
Affiliations
Simon Fraser University (CA)
Corresponding author
  • Walsby, Charles J.
  • Storr, Tim
Venue
Metallomics
Published
2015
Volume
7
Issue
1
Pages
129-135
ISSN
  • 1756-5901 (ISSN-L)
  • 1756-591X
OpenAlex
W2071350305
Cited by
50
References
79
Citations by year
2026: 5 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 5 · 2018: 4 · 2017: 4 · 2016: 2
FWCI
1.33
Type
journal article
Language
en
Open access
closed
Locations
  • Metallomics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Natural Sciences and Engineering Research Council of Canada
  • Michael Smith Foundation for Health Research
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
Keywords
KP1019, ruthenium(III) complexes, amyloid-beta, amyloid-beta aggregation, Alzheimer's disease, neurotoxicity, histidine binding, neuronal viability, drug repurposing
MeSH terms
Alzheimer Disease, Amyloid, Cell Survival, Humans, Indazoles, Organometallic Compounds, Amyloid beta-Peptides, Ruthenium Compounds, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.